• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1401941 BGB-3111 zanubrutinib Active ingredient Chemical Drugs(1.1) New Drug Application 2015-02-13 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2016-03-11 view
CXHL1401948 BGB-3111胶囊 zanubrutinib Capsule Chemical Drugs(1.1) New Drug Application 2015-02-13 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2016-03-11 view
CXHL1401942 BGB-3111胶囊 zanubrutinib Capsule Chemical Drugs(1.1) New Drug Application 2015-02-13 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2016-03-11 view
CXHS1800024 赞布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2018-08-29 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd Certificate Issued 2020-06-10 view
CXHS1800030 赞布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2018-10-24 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd Certificate Issued 2020-06-10 view
CXHL1900248 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2019-08-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2019-08-19 view
CXHL1900315 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) New Drug Application 2019-10-23 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2019-10-21 view
CXHB2000019 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs Supplementary Application 2020-03-24 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-03-23 view
CXHL2000142 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-04-09 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-04-08 view
CXHL2000143 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-04-09 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-04-08 view
CXHB2000072 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2020-08-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-08-19 view
CXHS2000037 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-09-30 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-09-30 view
CXHL2000611 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2020-12-02 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2020-12-01 view
CXHB2100005 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2021-01-09 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2021-01-08 view
CXHB2100034 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2021-03-04 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2021-03-04 view
CXHB2100057 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2021-04-10 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2022-01-27 view
CXHB2101014 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2021-04-23 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2101013 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) Supplementary Application 2021-04-23 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2101615 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(2.4) New Drug Application 2021-10-27 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2101135 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2021-10-28 BeiGene (Beijing) Co Ltd view